Thursday - July 16, 2026
Tool to predict brain swelling earns FDA Breakthrough Device designation
July 15, 2026
ST. LOUIS, Missouri, July 15 -- The Washington University School of Medicine posted the following news release:

* * *

Tool to predict brain swelling earns FDA Breakthrough Device designation

*

An AI-enabled software tool that predicts the development of dangerous brain swelling after a stroke has received Breakthrough Device designation by the U.S. Food and Drug Administration (FDA). Beacon-Neuro.AI Inc., a Washington University in St. Louis st . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products